公司資料
Waters Corporation 股價、新聞與催化劑
- 股票代碼:
- WAT
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
425.53 USD (-3.15%)
收盤價
最後更新: 2026年10月1日
36.5B USD
市值
股價為何變動
截至 2026年10月1日，WAT 下跌 3.15%，收於 $425.53。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Life-Science and Diagnostics Technology Company
Waters provides analytical technologies, laboratory instruments, consumables, informatics, and services used in regulated and high-volume scientific workflows. Its customers include pharmaceutical and biotechnology companies, clinical laboratories, academic institutions, industrial laboratories, and food, environmental, and materials-testing organizations.
Analytical Sciences Division
The Analytical Sciences business is built around liquid chromatography, mass spectrometry, thermal analysis, rheology, and related software and chemistry consumables. These systems are used for drug discovery, process development, quality control, release testing, and characterization of complex molecules and materials.
Biosciences Portfolio
The Biosciences division adds flow cytometry, cell analysis, antibodies, reagents, and tools used to study cellular function and immune biology. This portfolio expands Waters beyond separation science into research and translational workflows that measure cells, proteins, and other biological systems.
Clinical and Diagnostic Solutions
Waters supplies diagnostic systems and assays used in hospital and reference laboratories, including technologies for infectious disease, microbiology, and routine clinical testing. Its emphasis on regulated workflows, automation, and reproducibility aligns the diagnostics business with the company's established strengths in high-throughput analytical environments.
Consumables, Informatics, and Service Model
Instrument placements support recurring revenue from columns, reagents, kits, software, maintenance, and laboratory services. The combined company therefore serves customers through an integrated model spanning capital equipment, workflow consumables, informatics, technical support, and compliance-oriented services.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。